Sleep Apnoea Costs UK Workplaces Billions Annually, Study Reveals
Researchers are calling for widespread workplace screening of employees for obstructive sleep apnoea (OSA), citing staggering annual productivity losses estimated at up to £4.22 billion across the United Kingdom. This common sleep disorder affects approximately eight million people nationwide, yet a concerning 85 per cent of cases remain undiagnosed, according to recent findings.
Economic Impact and Undiagnosed Cases
The study highlights that OSA, characterised by repeated breathing interruptions during sleep, leads to severe daytime sleepiness and impaired cognitive function. This directly translates into reduced work efficiency, increased absenteeism, and higher accident rates. With millions undiagnosed, the economic burden on businesses is substantial, impacting sectors from manufacturing to professional services.
Proposed Screening and High-Risk Roles
Experts advocate for a pilot screening scheme targeting high-risk occupations, such as professional driving, where drowsiness poses significant public safety dangers. Early identification through workplace initiatives could mitigate risks and enhance operational safety. The research underscores that proactive measures are essential to address this hidden health crisis.
Treatment Options and Economic Savings
Effective management of OSA, including improving adherence to Continuous Positive Airway Pressure (Cpap) therapy and exploring new non-Cpap treatments, could yield considerable economic savings. Timely intervention not only boosts individual health but also restores productivity, potentially saving billions for the UK economy annually.
Union and Charity Perspectives
Workers' unions and sleep apnoea charities emphasise the importance of supportive workplace policies. They argue that employees diagnosed with OSA should receive employment guarantees and necessary accommodations, rather than facing penalisation. This approach fosters a healthier workforce and aligns with ethical employment practices.
In summary, addressing obstructive sleep apnoea through screening and support represents a critical opportunity for UK workplaces to enhance productivity, ensure safety, and achieve significant financial benefits.
